FibroScan® is the original, non-invasive solution for assessing liver fibrosis and steatosis at the point-of-care in an exam that takes as little as four minutes.
Unlike other elastography tools, FibroScan® uniquely delivers proprietary biomarkers (LSM by VCTE®, CAP, and SSM by VCTE®), recognized by clinical guidelines, payer policies, and approved drug labeling.
Fast, quantitative, and standardized, FibroScan® provides the clarity clinicians need to detect risk earlier, guide informed decisions, and support ongoing management using measurements relied upon worldwide.
FibroScan® exams are widely covered by insurance and used across various specialties, including hepatology, gastroenterology, endocrinology, obesity medicine, and primary care.
Corporate Educational Partnerships
Exact Sciences is now Abbott, bringing our leading portfolio of cancer screening and diagnostics tests to the most diversified company in health. Our solutions help patients and healthcare providers make timely, informed decisions before, during and after a cancer diagnosis. Our growing product line includes well-established brands such as Cologuard and Oncotype DX, along with innovative solutions like the Cancerguard test for multi-cancer early detection and the Oncodetect test for molecular residual disease and recurrence monitoring. We continue to invest in a robust pipeline of advanced diagnostics aimed at improving outcomes. For more information, visit ExactSciences.com.
https://www.forvismazars.us/